1. Home
  2. KTTA vs MFC Comparison

KTTA vs MFC Comparison

Compare KTTA & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • MFC
  • Stock Information
  • Founded
  • KTTA 2020
  • MFC 1887
  • Country
  • KTTA United States
  • MFC Canada
  • Employees
  • KTTA N/A
  • MFC N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • MFC Life Insurance
  • Sector
  • KTTA Health Care
  • MFC Finance
  • Exchange
  • KTTA Nasdaq
  • MFC Nasdaq
  • Market Cap
  • KTTA 5.5M
  • MFC 49.3B
  • IPO Year
  • KTTA 2021
  • MFC 1999
  • Fundamental
  • Price
  • KTTA $0.69
  • MFC $30.25
  • Analyst Decision
  • KTTA
  • MFC Buy
  • Analyst Count
  • KTTA 0
  • MFC 1
  • Target Price
  • KTTA N/A
  • MFC $51.00
  • AVG Volume (30 Days)
  • KTTA 130.6K
  • MFC 2.4M
  • Earning Date
  • KTTA 08-12-2025
  • MFC 08-06-2025
  • Dividend Yield
  • KTTA N/A
  • MFC 3.95%
  • EPS Growth
  • KTTA N/A
  • MFC 14.95
  • EPS
  • KTTA N/A
  • MFC 1.85
  • Revenue
  • KTTA N/A
  • MFC $20,887,744,800.00
  • Revenue This Year
  • KTTA N/A
  • MFC $35.15
  • Revenue Next Year
  • KTTA N/A
  • MFC $5.64
  • P/E Ratio
  • KTTA N/A
  • MFC $16.41
  • Revenue Growth
  • KTTA N/A
  • MFC 9.27
  • 52 Week Low
  • KTTA $0.67
  • MFC $23.30
  • 52 Week High
  • KTTA $7.50
  • MFC $33.07
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 32.12
  • MFC 38.17
  • Support Level
  • KTTA $0.67
  • MFC $30.22
  • Resistance Level
  • KTTA $0.77
  • MFC $30.63
  • Average True Range (ATR)
  • KTTA 0.03
  • MFC 0.48
  • MACD
  • KTTA 0.01
  • MFC -0.14
  • Stochastic Oscillator
  • KTTA 17.53
  • MFC 1.13

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About MFC Manulife Financial Corporation

Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.

Share on Social Networks: